Buch, Englisch, 403 Seiten, Format (B × H): 184 mm x 259 mm, Gewicht: 1057 g
Reihe: Infectious Disease
Buch, Englisch, 403 Seiten, Format (B × H): 184 mm x 259 mm, Gewicht: 1057 g
Reihe: Infectious Disease
ISBN: 978-1-58829-230-8
Verlag: Humana Press
A comprehensive and cutting-edge review of how practicing physicians can best treat multiple drug resistance in bacterial, viral, protozoal, and helminthic infections. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegalovirals is also discussed, as are those measures necessary to prevent the spread of infections patients.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
I: Gram-Positive Bacteria.- 1 Management of Community-Acquired Pneumonia Caused by Drug-Resistant Streptococcus pneumoniae.- 2 Management of Meningitis Caused by Resistant Streptococcus pneumoniae.- 3 Emerging Resistance to Vancomycin, Rifampin, and Fluoroquinolones in Streptococcus pneumoniae.- 4 Management of Glycopeptide-Resistant Staphylococcus aureus Infections.- 5 Infections Caused by Glycopeptide-Resistant Gram-Positive Bacteria Excluding Staphylococci.- 6 Isolation Policies and the Hospital Management of Methicillin-Resistant Staphylococcus aureus: A Case of Evidence-Free Medicine?.- II: Gram-Negative Pathogens.- 7 The Management of Resistant Acinetobacter Infections in the Intensive Therapy Unit.- 8 Drug-Resistant Helicobacter pylori.- 9 The Management of Antibiotic-Resistant Neisseria gonorrhoeae.- 10 Management of Urinary Tract Infections Caused by Multiresistant Organisms.- 11 Management of Multiple Drug-Resistant Salmonella Infections.- 12 Management of Melioidosis.- III: Mycobacteria.- 13 The Molecular Epidemiology of MDR-TB.- 14 The Management of Multiple Drug-Resistant Tuberculosis.- 15 Management of Infection With Nontuberculosis Mycobacteria.- IV: Fungal and Parasitic Infections.- 16 Management of Resistant Candida Infections.- 17 Management of Infection With Naturally Amphotericin B-Resistant Fungi.- 18 Management of Multiple Drug-Resistant Malaria.- 19 Schistosome Drug Resistance: Praziquantel.- V. Viral Infections.- 20 Management of HIV Drug-Resistant Infections.- 21 Multidrug Resistance in Human Cytomegalovirus.
